2 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Secukinumab Open Label Roll-over Extension ProtocolInflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, autoimmune disease, immune system disorderRecruitingPhase 42026-09-28NCT04638647
Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR)Skin and Connective Tissue Diseases, connective tissue disorder, muscle tissue disorder, musculoskeletal system disorder, polymyalgia rheumatica, rheumatic disorderActive, not recruitingPhase 32026-08-21NCT06331312